As the next generation of therapies are developed, HLA matching will play an important role for a number of leading-edge therapeutics, including allogeneic cellular therapies.
As the importance of HLA grows in relation to the development of new therapies, one of our primary objectives at Be The Match BioTherapies® is utilizing our amassed historical data to develop search and matching algorithms to ensure patients receive the therapies with the greatest probability of success. Understanding how HLA matching components will impact cell bank set-ups and population coverage is a necessity for any organization with an emerging therapy in its pipeline.
Attend this webinar for an in-depth presentation from Martin Maiers, MS, Vice President of Biomedical Informatics at our research partner, the CIBMTR®, and a live Q&A featuring well-known industry professionals.
As a webinar attendee, you will learn about: